Claritev Corporation/$CTEV

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Claritev Corporation

Claritev Corp is a healthcare technology, data, and insights company focused on improving transparency, affordability, and quality. The company provides tech-enabled solutions and services to interpret clients' needs and customize solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment, and revenue integrity solutions to the U.S. healthcare industry.

Ticker

$CTEV
Sector

Primary listing

NYSE

Employees

2,700

CTEV Metrics

BasicAdvanced
$1.2B
-
-$40.80
0.50
-

Bulls say / Bears say

Claritev returned to topline growth with Q2 2025 revenues rising 3.5% year-over-year to $241.6 million, beating analyst forecasts and marking its first sequential increase after previous declines. (Nasdaq)
Strong operating cash generation drove free cash flow to a positive $36.6 million in Q2 2025, a marked improvement from a $7 million outflow in the prior-year period. (Nasdaq)
Analysts maintain a consensus ‘Buy’ rating on CTEV with an average price target of $86, implying approximately 55% upside from current levels. (Stockanalysis)
A U.S. judge ruled that out-of-network providers can pursue price-fixing claims against Claritev and major insurers, exposing the company to substantial antitrust litigation risk. (Reuters)
The U.S. Justice Department has sided with medical providers in alleging that Claritev’s pricing algorithms may facilitate anticompetitive behavior, increasing the probability of regulatory action and damages. (Reuters)
Claritev’s largest business line, Analytics-Based services, saw a 1.8% year-over-year revenue decline in Q2 2025, highlighting potential growth headwinds in its core segment. (Investing.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Oct 2025.
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $CTEV

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs